PMC4996991_01
Pelvic magnetic resonance image. Sagittal T2-weighted magnetic resonance image showing endometrial cancer as heterogeneous intermediate-signal intensity lesion (white asterisk) disrupting the normal high-signal intensity endometrium and infiltrating less than half of the ventral myometrial thickness (revised FIGO IA Stage).
fonc-06-00190-g001.jpg
PMC4996991_01_fonc-06-00190-g001.jpg
F1
T2-weighted image a 2 cm x 2.5 cm area of heterogeneous intermediate-signal intensity lesion disrupting the normal high-signal intensity endometrium and invading less than half of the myometrium (Figure 1). Then, in January 2015, she underwent hysterectomy and bilateral oophorectomy.
Histology of the primary endometrial cancer and the ileum recurrence. (A) Moderately differentiated endometrioid adenocarcinoma (G2). Superficial myometrial invasion of the tumor (arrow) (hematoxylin-eosin staining, x20). (B) Endometrioid adenocarcinoma metastating to the ileum. The tumor invades bowel mucosa (arrow) and stroma connective adipose subserous (hematoxylin-eosin staining, x20).
fonc-06-00190-g002.jpg
PMC4996991_01_fonc-06-00190-g002.jpg
F2
The final histopathology reported a 2 cm x 1 cm G2 endometrioid EC with a 30% myometrial deep invasion (FIGO Stage 1A) (Figure 2A). The final histopathology was positive for EC recurrence at ileum, omentum, and vaginal wall (Figure 2B).